440 related articles for article (PubMed ID: 22879423)
1. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center.
Bernstein PS; Ahmed F; Liu A; Allman S; Sheng X; Sharifzadeh M; Ermakov I; Gellermann W
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6178-86. PubMed ID: 22879423
[TBL] [Abstract][Full Text] [Related]
2. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
3. Interrelationships between maternal carotenoid status and newborn infant macular pigment optical density and carotenoid status.
Henriksen BS; Chan G; Hoffman RO; Sharifzadeh M; Ermakov IV; Gellermann W; Bernstein PS
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5568-78. PubMed ID: 23838770
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
[TBL] [Abstract][Full Text] [Related]
5. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
Bernstein PS; Zhao DY; Wintch SW; Ermakov IV; McClane RW; Gellermann W
Ophthalmology; 2002 Oct; 109(10):1780-7. PubMed ID: 12359594
[TBL] [Abstract][Full Text] [Related]
6. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Stringham JM; Stringham NT
Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
[TBL] [Abstract][Full Text] [Related]
7. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
[TBL] [Abstract][Full Text] [Related]
8. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
Zeimer M; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Ophthalmologe; 2009 Jan; 106(1):29-36. PubMed ID: 18551295
[TBL] [Abstract][Full Text] [Related]
9. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
[TBL] [Abstract][Full Text] [Related]
10. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
Richer S; Devenport J; Lang JC
Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
[TBL] [Abstract][Full Text] [Related]
11. Blue-light reflectance imaging of macular pigment in infants and children.
Bernstein PS; Sharifzadeh M; Liu A; Ermakov I; Nelson K; Sheng X; Panish C; Carlstrom B; Hoffman RO; Gellermann W
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4034-40. PubMed ID: 23652486
[TBL] [Abstract][Full Text] [Related]
12. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
14. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
15. Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation.
Corvi F; Souied EH; Falfoul Y; Georges A; Jung C; Querques L; Querques G
Br J Ophthalmol; 2017 Jun; 101(6):770-773. PubMed ID: 27587715
[TBL] [Abstract][Full Text] [Related]
16. The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study-carotenoid supplementation during pregnancy: ocular and systemic effects-study protocol for a randomized controlled trial.
Addo EK; Gorusupudi A; Allman S; Bernstein PS
Trials; 2021 Apr; 22(1):300. PubMed ID: 33888136
[TBL] [Abstract][Full Text] [Related]
17. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative.
LaRowe TL; Mares JA; Snodderly DM; Klein ML; Wooten BR; Chappell R;
Ophthalmology; 2008 May; 115(5):876-883.e1. PubMed ID: 17868874
[TBL] [Abstract][Full Text] [Related]
18. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
19. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
[TBL] [Abstract][Full Text] [Related]
20. Correlations Between Macular, Skin, and Serum Carotenoids.
Conrady CD; Bell JP; Besch BM; Gorusupudi A; Farnsworth K; Ermakov I; Sharifzadeh M; Ermakova M; Gellermann W; Bernstein PS
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3616-3627. PubMed ID: 28728169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
